Effect of antiplatelet agent on muscle cramps in patients with lumbar spinal canal stenosis and peripheral artery disease

Effect of antiplatelet agent on muscle cramps in patients with lumbar spinal canal stenosis and peripheral artery disease - Effect of antiplatelet agent on muscle cramps in patients with lumbar spinal canal stenosis and peripheral artery disease

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000006633

Enrollment

Registered

2011-11-01

Start date

2011-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lumbar spinal canal stenosis

Interventions

Continuous administration of cilostazol

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Lumbar spinal canal stenosis Administration of limaprost alfadex Peripheral artery disease Nocturnal muscle cramps Patients who have given informed consent to participation in the study

Exclusion criteria

Exclusion criteria: Patients who are bleeding Congestive heart failure Patients with a history of hypersensitivity to any of the ingredients of this drug Pregnant women or women having possibilities of being pregnant

Design outcomes

Primary

Measure	Time frame
Subjective symptom of muscle cramps on questionnaire	—

Countries

Japan

Contacts

Public ContactIkuho Yonezawa

Juntendo University Department of Orthopaedic Surgery

03-3813-3111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026